If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Trading Update

9 Jan 2019 07:00

RNS Number : 5585M
Ted Baker PLC
09 January 2019
 

9 January 2019

Ted Baker Plc

("Ted Baker" or the "Group")

Trading Update

For the 5 week period from 2 December 2018 to 5 January 2019

"Good performance reflecting strength of the brand"

Ted Baker, the global lifestyle brand, announces that retail sales increased by 12.2% (10.5% in constant currency) for the five week period from 2 December 2018 to 5 January 2019 (the "period"), compared to the same period last year. E-commerce sales increased by 18.7% (17.7% in constant currency) and represented 25.7% of total retail sales (2018: 24.3%). Average retail square footage rose by 5.0% to 429,576 sq.ft (2018: 409,226 sq.ft).

Against a backdrop of increased promotional activity, gross margins remain in line with our expectations for the full year and we expect to end the year with a clean stock position. Accordingly, the Board anticipates that results for the 52 weeks ending 26 January 2019 will be in line with its expectations.

 

We intend to announce our Annual Results for the 52 weeks ending 26 January 2019 on 21 March 2019.

 

Commenting on trading, Lindsay Page, Acting Chief Executive Officer said:

 

"The Ted Baker brand has delivered a good performance across both our stores and e-commerce business, despite the continuing challenging external trading conditions across our markets. This result again reflects the strength of the brand and the quality of our collections.

 

I would like to take this opportunity to thank our teams for their outstanding enthusiasm, skill and commitment throughout this key period and our global partners for their continued support."

 

Acquisition of No Ordinary Shoes Limited and No Ordinary Shoes USA LLC

 

Further to our announcement on 10 September 2018 and as anticipated, we completed the acquisition of No Ordinary Shoes Limited and No Ordinary Shoes USA LLC on 1 January 2019 for a consideration of £20.3m, subject to the finalisation of completion accounts. This is an exciting opportunity to drive further growth in our footwear business by leveraging our global footprint and well invested infrastructure. The acquisition is expected to enhance the earnings of Ted Baker in FY2019/20 and beyond.

 

Independent external investigation

 

The work of the independent external investigation conducted by Herbert Smith Freehills LLP in respect of the recent media reports and petition is progressing and a further update will be made in due course.

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the Group is Charles Anderson, Finance Director & Company Secretary.

 

 

Ted Baker

Tel: +44 (0) 20 7255 4800

Lindsay Page, Acting Chief Executive Officer

 

Charles Anderson, Finance Director & Company Secretary

 

 

 

Hudson Sandler

Tel: +44 (0) 20 7796 4133

Alex Brennan / Hattie O'Reilly / Nick Moore

 

 

Enquiries and further information:

www.tedbaker.com

www.tedbakerplc.com

 

Media images available for download at:

www.tedbakerplc.com/ted/en/mediacentre/imagelibrary

 

Cautionary statement regarding forward-looking statements

This announcement contains certain forward-looking statements. These forward-looking statements include matters that are not historical facts or are statements regarding the Group's intentions, beliefs or current expectations concerning, among other things, the Group's results of operations, financial condition, liquidity, prospects, growth, strategies, and the industries in which the Group operates.

Forward-looking statements are based on the information available to the Directors at the time of preparation of this announcement, and will not be updated. The Directors can give no assurance that these expectations will prove to have been correct. Due to inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTMMGGMRRZGLZM
Date   Source Headline
18th Mar 20228:20 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSStatement re Possible Offer
7th Mar 20221:01 pmRNSHolding(s) in Company
23rd Feb 20227:00 amRNSQ4 2022 / Pre-close trading update
17th Dec 20213:04 pmRNSBoard composition
6th Dec 20217:00 amRNSJohn Barton
1st Dec 20214:56 pmRNSTotal Voting Rights
11th Nov 202110:48 amRNSReplacement Interim Results
11th Nov 20217:00 amRNSInterim Results
5th Nov 202112:04 pmRNSDirectorate Change
2nd Nov 20213:13 pmRNSBlock listing Interim Review
6th Oct 20214:17 pmRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSNew Joint Broker
7th Sep 20217:00 amRNSQ2 Trading Update
4th Aug 20217:00 amRNSDirectorate Change
3rd Aug 202111:22 amRNSDirector/PDMR Shareholding
28th Jul 20213:12 pmRNSNotice of Results
28th Jul 20217:00 amRNSNotice of Q2 Trading Update
23rd Jul 20217:00 amRNSNew Global HQ
28th Jun 20217:00 amRNSNotice of AGM
17th Jun 20217:00 amRNSHolding(s) in Company
14th Jun 20217:00 amRNSFinal Results
9th Jun 20213:11 pmRNSChange to Full Year Results Date
25th May 20217:00 amRNSSuccessful bank refinancing
24th May 20217:00 amRNSChange to Full Year Results Date
13th May 20217:00 amRNSHolding(s) in Company
6th May 20212:54 pmRNSBlock listing Interim Review
29th Apr 202110:55 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSTed Baker announces new territory licence deals
24th Feb 202112:30 pmRNSAdditional Listing
11th Feb 20217:00 amRNSNotice of Results
4th Feb 202110:01 amRNSTotal Voting Rights
8th Jan 20213:47 pmRNSNotice of Results
16th Dec 20206:35 pmRNSDirector/PDMR Shareholding
7th Dec 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSChange to Interim Results Date
3rd Nov 20205:07 pmRNSBlock listing Interim Review
2nd Nov 202011:49 amRNSHolding(s) in Company
26th Oct 202010:50 amRNSDirector/PDMR Shareholding
14th Oct 202011:31 amRNSNotice of Results
7th Oct 20204:56 pmRNSHolding(s) in Company
6th Oct 20202:34 pmRNSTotal Voting Rights
30th Sep 202010:17 amRNSDirector/PDMR Shareholding
4th Sep 20202:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20204:26 pmRNSDirector/PDMR Shareholding
1st Sep 202010:10 amRNSDirectorate Change
18th Aug 20205:13 pmRNSDirector/PDMR Shareholding
4th Aug 202011:58 amRNSTotal Voting Rights
24th Jul 20205:54 pmRNSHolding(s) in Company
21st Jul 202012:17 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.